You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,293,794


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,293,794
Title:Methods and compositions for the treatment of CNS-related conditions
Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
Inventor(s): Went; Gregory T. (Mill Valley, CA), Fultz; Timothy J. (Pleasant Hill, CA), Meyerson; Laurence R. (Las Vegas, NV)
Assignee: Adamas Pharmaceuticals, Inc. (Emeryville, CA)
Application Number:12/753,769
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,293,794
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,293,794

Introduction

United States Patent 8,293,794, titled "Methods and compositions for the treatment of CNS-related conditions," is a significant patent in the field of neurology and pharmacology. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

US Patent 8,293,794 was granted to address novel methods and compositions for the treatment and prevention of Central Nervous System (CNS)-related conditions. The patent describes specific compounds, their synthesis, and their therapeutic applications[2].

Scope of the Patent

The scope of a patent defines the boundaries of what is protected by the patent. For US Patent 8,293,794, the scope includes:

Claims

The patent claims are the most critical part of the patent document as they define the legal boundaries of the invention. Here, the claims cover:

  • Composition Claims: These claims specify the chemical compounds and their formulations used for treating CNS-related conditions.
  • Method Claims: These claims outline the methods of using these compounds for therapeutic purposes.
  • Use Claims: These claims define the specific uses of the compounds, such as the treatment of particular CNS-related conditions[2].

Description and Drawings

The patent provides a detailed description of the invention, including the synthesis of the compounds, their pharmacological properties, and any relevant drawings or diagrams that illustrate the invention.

Detailed Analysis of Claims

To understand the patent's scope, it is crucial to analyze each claim individually.

Independent Claims

Independent claims stand alone and do not rely on other claims. For US Patent 8,293,794, these claims typically describe the broadest aspects of the invention, such as the novel compounds and their therapeutic uses.

Dependent Claims

Dependent claims build upon independent claims and provide more specific details. These claims might include specific dosages, administration methods, or particular CNS-related conditions that the compounds can treat.

Patent Landscape

The patent landscape surrounding US Patent 8,293,794 involves several key aspects:

Prior Art

Prior art refers to existing knowledge and inventions in the field before the filing date of the patent. The Common Citation Document (CCD) and other tools like the Patent Public Search can help identify prior art cited by various patent offices, ensuring that the invention is novel and non-obvious[1].

Global Patent Family

Using tools like the Global Dossier, one can identify related applications filed at participating IP Offices. This helps in understanding the global reach and protection of the invention[1].

Competitor Patents

Analyzing patents held by competitors in the same field can reveal gaps and opportunities. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) are invaluable for this purpose[1].

Search and Analysis Tools

Several tools are available for searching and analyzing patents:

Patent Public Search

This tool replaced legacy search tools and provides enhanced access to prior art with modern interfaces[1].

Global Dossier

This service allows users to view the file histories of related applications from participating IP Offices, including office actions and citation data[1].

Patent Claims Research Dataset

This dataset, provided by the USPTO, contains detailed information on claims from US patents and applications, which can be used to analyze patent scope and trends[3].

Legal and Regulatory Considerations

Understanding the legal and regulatory environment is crucial for maintaining and enforcing patent rights.

Patent Assignment and Ownership

The Patent Assignment Search website can be used to track changes in ownership, ensuring that the patent is properly assigned and maintained[1].

Litigation and Infringement

In cases of patent infringement, understanding the legal framework and precedents is vital. Documents from court cases, such as those available through legal databases, can provide insights into how similar patents have been litigated[5].

Industry Impact and Trends

The impact of US Patent 8,293,794 on the pharmaceutical and biotechnology industries can be significant.

Therapeutic Applications

The patent's focus on CNS-related conditions makes it a valuable asset in the development of new treatments for diseases such as Alzheimer's, Parkinson's, and depression.

Market Competition

The patent landscape in this field is highly competitive. Companies holding similar patents must navigate the complex web of intellectual property rights to avoid infringement and to protect their own innovations.

Conclusion

US Patent 8,293,794 is a critical invention in the field of CNS-related treatments. Understanding its scope, claims, and the broader patent landscape is essential for researchers, pharmaceutical companies, and legal professionals.

Key Takeaways

  • Scope and Claims: The patent covers specific compounds, methods of use, and therapeutic applications for CNS-related conditions.
  • Patent Landscape: Tools like the Global Dossier and Patent Public Search are crucial for analyzing prior art and competitor patents.
  • Legal Considerations: Tracking patent assignments and understanding litigation precedents are vital for maintaining and enforcing patent rights.
  • Industry Impact: The patent has significant implications for the development of new treatments in the pharmaceutical and biotechnology industries.

FAQs

  1. What is the main focus of US Patent 8,293,794?

    • The main focus is on novel methods and compositions for the treatment and prevention of CNS-related conditions.
  2. How can one search for prior art related to this patent?

    • Tools like the Patent Public Search and the Common Citation Document (CCD) can be used to identify prior art.
  3. What is the Global Dossier, and how is it useful?

    • The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent family.
  4. Where can one find detailed information on patent claims?

    • The Patent Claims Research Dataset provided by the USPTO contains detailed information on claims from US patents and applications.
  5. How can changes in patent ownership be tracked?

    • The Patent Assignment Search website can be used to track changes in ownership and ensure proper assignment and maintenance of the patent.

Sources

  1. USPTO - Search for patents
  2. US8293794B2 - Methods and compositions for the treatment of CNS ...
  3. USPTO - Patent Claims Research Dataset
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office
  5. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT ...

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,293,794

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-003 Jul 18, 2016 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-001 Dec 23, 2014 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-004 Jul 18, 2016 AB RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206439-002 Dec 23, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,293,794

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E481096 ⤷  Subscribe
Australia 2005209310 ⤷  Subscribe
Australia 2005215767 ⤷  Subscribe
Australia 2005215775 ⤷  Subscribe
Australia 2005309601 ⤷  Subscribe
Australia 2006244297 ⤷  Subscribe
Brazil PI0518483 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.